Experiment 1 Sample Clauses

Experiment 1 preliminar evaluation. The first experiment was done at the beginning of annotation process. The objec- tive was to know the level of agreement between annotators without the annotation guide and without any training process. The results obtained in this experiment will be compared with the results obtained in the experiment 2. In this first experiment we have compared the annotation of four specific words with high frequency in the corpus: one verb (“decir”: to say), one adjective (“pri- mero”: first), one abstract noun (“vida”: life) and one concrete noun (“hombre”: man). All occurrences of these words in the corpus were annotated by two annotators. The results are shown in Table 1. The results show that the agreement between annotators at the beginning of the annotation process is very low. Indeed, in the annotation of the verb and the adjective, the agreement according to kappa coefficient (see later) is 0, that is, the agreement between annotators is the agreement expected by chance. On other hand, as is shown in [21], the level of ambiguity is different in each part of speech. Effectively, according to this preliminar experiment, adjectives are more ambiguous than verbs and nouns; and abstract nouns are more ambiguous than concrete nouns.
Sample 1
AutoNDA by SimpleDocs
Experiment 1. Simple static allocation This section describes the results we obtained in Experiment 1. Figure 5 shows the throughput of the system during the experiment. After load level 30, we do not observe any growth in the system’s throughput because one or both of the tiers have reached their saturation points. Although the load level increases with time, the system is unable to serve all requests, and it either rejects or queues the remaining requests.
Sample 1
Experiment 1. Static resource allocation to Web application In this experiment, I established an experimental setup in which only one virtual machine (VM1) hosts the Web application. Figure 4.1 shows the experimental setup established for this experiment. The Ngnix based Web farm consists of only one virtual machine (VM1). VLBManager is only used to obtain the average response time by actively monitoring the Ngnix logs.
Sample 1
Experiment 1. In our first experiment, we manipulated the overt-case marking of the subject head.
Sample 1

Related to Experiment 1

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Trials The Ship shall run the following test and trials:

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Research Support opioid abatement research that may include, but is not limited to, the following:

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

Time is Money Join Law Insider Premium to draft better contracts faster.